Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-09-14
1991-07-30
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514444, 514529, 514530, 514534, 544 59, 544168, 544171, 544397, 546234, 546239, 548568, 548572, 549 59, 549 77, 560 58, 560118, 564171, 564188, C07C 69732, C07D33322, A61K 31215, A61K 3138
Patent
active
050360981
ABSTRACT:
Compounds of the formula (I): ##STR1## exhibit anti-cholingeric and calcium antagonistic action and are used for treating pollakiuria and incontinence in humans and animals.
REFERENCES:
The Merck Index, 11th ed. (1989), Budavari (editor), p. 1100, Merck and Co., Inc.
Carol S. Weil, "Tables for Convenient Calculation of Median Effective Dose (LD.sub.50 OR-ED.sub.50) And Instructions in Their Use", Biometrics, 8, 249-253 (1952).
Kimura Kiyoshi
Kise Masahiro
Morita Iwao
Datlow Philip
Nippon Shinyaku Co. Ltd.
Shah Mukund J.
LandOfFree
Butynylamine derivatives and their production does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Butynylamine derivatives and their production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Butynylamine derivatives and their production will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1542914